Squarepoint’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $64.9M | Buy |
184,314
+169,964
| +1,184% | +$60.6M | 0.08% | 258 |
|
|
2025
Q4 | $4.7M | Sell |
14,350
-41,815
| -74% | -$13.3M | 0.01% | 1507 |
|
|
2025
Q3 | $15.8M | Buy |
56,165
+36,170
| +181% | +$10.5M | 0.02% | 861 |
|
|
2025
Q2 | $5.58M | Sell |
19,995
-259,544
| -93% | -$73.5M | 0.01% | 1386 |
|
|
2025
Q1 | $87.1M | Buy |
279,539
+191,654
| +218% | +$56.6M | 0.11% | 187 |
|
|
2024
Q4 | $22.9M | Buy |
87,885
+73,419
| +508% | +$21.8M | 0.02% | 710 |
|
|
2024
Q3 | $4.66M | Sell |
14,466
-7,687
| -35% | -$2.51M | 0.01% | 1463 |
|
|
2024
Q2 | $6.92M | Sell |
22,153
-111,234
| -83% | -$32.7M | 0.01% | 1154 |
|
|
2024
Q1 | $37.9M | Buy |
133,387
+118,886
| +820% | +$34.8M | 0.07% | 351 |
|
|
2023
Q4 | $4.18M | Sell |
14,501
-205,338
| -93% | -$55.9M | 0.01% | 1504 |
|
|
2023
Q3 | $59.1M | Sell |
219,839
-258,645
| -54% | -$64.5M | 0.15% | 130 |
|
|
2023
Q2 | $106M | Buy |
478,484
+166,100
| +53% | +$38.5M | 0.33% | 39 |
|
|
2023
Q1 | $75.5M | Buy |
312,384
+124,193
| +66% | +$30.5M | 0.31% | 48 |
|
|
2022
Q4 | $49.4M | Sell |
188,191
-64,282
| -25% | -$17.2M | 0.2% | 89 |
|
|
2022
Q3 | $56.9M | Sell |
252,473
-78,896
| -24% | -$19.1M | 0.29% | 52 |
|
|
2022
Q2 | $80.6M | Buy |
331,369
+246,490
| +290% | +$60.4M | 0.45% | 30 |
|
|
2022
Q1 | $20.5M | Buy |
84,879
+32,295
| +61% | +$7.42M | 0.09% | 233 |
|
|
2021
Q4 | $11.8M | Sell |
52,584
-83,302
| -61% | -$17.6M | 0.03% | 474 |
|
|
2021
Q3 | $28.9M | Buy |
135,886
+60,563
| +80% | +$13.9M | 0.08% | 225 |
|
|
2021
Q2 | $18.4M | Buy |
75,323
+50,154
| +199% | +$12.3M | 0.07% | 264 |
|
|
2021
Q1 | $6.26M | Sell |
25,169
-53,815
| -68% | -$12.8M | 0.04% | 535 |
|
|
2020
Q4 | $18.2M | Buy |
+78,984
| New | +$18.2M | 0.14% | 135 |
|
|
2020
Q2 | – | Sell |
-2,564
| Closed | -$520K | – | 2203 |
|
|
2020
Q1 | $520K | Sell |
2,564
-13,136
| -84% | -$2.87M | 0.01% | 1018 |
|
|
2019
Q4 | $3.79M | Sell |
15,700
-121,660
| -89% | -$26.8M | 0.02% | 599 |
|
|
2019
Q3 | $26.6M | Buy |
137,360
+27,960
| +26% | +$5.37M | 0.24% | 89 |
|
|
2019
Q2 | $20.2M | Buy |
109,400
+56,300
| +106% | +$10.1M | 0.2% | 119 |
|
|
2019
Q1 | $10.1M | Buy |
53,100
+46,163
| +665% | +$8.82M | 0.11% | 231 |
|
|
2018
Q4 | $1.35M | Sell |
6,937
-57,031
| -89% | -$11.1M | 0.02% | 814 |
|
|
2018
Q3 | $13.3M | Sell |
63,968
-39,892
| -38% | -$7.86M | 0.16% | 172 |
|
|
2018
Q2 | $19.2M | Buy |
103,860
+76,347
| +277% | +$13.5M | 0.25% | 83 |
|
|
2018
Q1 | $4.69M | Sell |
27,513
-23,154
| -46% | -$4.25M | 0.07% | 324 |
|
|
2017
Q4 | $8.81M | Buy |
50,667
+20,603
| +69% | +$3.65M | 0.15% | 144 |
|
|
2017
Q3 | $5.61M | Buy |
30,064
+1,164
| +4% | +$206K | 0.11% | 241 |
|
|
2017
Q2 | $4.98M | Sell |
28,900
-110,928
| -79% | -$18M | 0.1% | 262 |
|
|
2017
Q1 | $22.9M | Buy |
139,828
+108,827
| +351% | +$18.1M | 0.63% | 17 |
|
|
2016
Q4 | $4.53M | Sell |
31,001
-4,499
| -13% | -$677K | 0.19% | 123 |
|
|
2016
Q3 | $5.92M | Buy |
+35,500
| New | +$6M | 0.39% | 50 |
|
|
2016
Q2 | – | Sell |
-10,135
| Closed | -$1.52M | – | 1084 |
|
|
2016
Q1 | $1.52M | Buy |
10,135
+7,589
| +298% | +$1.13M | 0.12% | 239 |
|
|
2015
Q4 | $413K | Buy |
+2,546
| New | +$400K | 0.05% | 635 |
|
|
2015
Q1 | – | Sell |
-2,400
| Closed | -$382K | – | 417 |
|
|
2014
Q4 | $382K | Buy |
+2,400
| New | +$374K | 0.37% | 106 |
|
Other funds holding AMGN
VCM
VPM
Squarepoint's AMGN Position: Q1 2026 in Review
Squarepoint increased its Amgen (AMGN) stake by 1,184% in Q1 2026, buying an estimated $60.6M and bringing the position to 184,314 shares worth $64.9M. The position accounts for 0.08% of the portfolio, ranked #258.
Squarepoint first reported a position in AMGN in Q4 2014 and has held it in 40 quarters since. The position peaked at $106M in Q2 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Squarepoint held 184,314 shares of Amgen worth $64.9M as of Q1 2026.
- Squarepoint bought 169,964 Amgen shares in Q1 2026, an estimated $60.6M.
- Amgen made up 0.08% of Squarepoint's portfolio in Q1 2026, its #258 holding.
- Squarepoint first reported a position in Amgen in Q4 2014 and has held it in 40 quarters since.
- Squarepoint's Amgen position peaked at $106M in Q2 2023.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.